SlideShare ist ein Scribd-Unternehmen logo
1 von 95
Neoplasia
-BY SURAJ DHARA
(MMCH)
Neoplasia
Upon completion of these lectures, the student should:
 Define a neoplasm. Contrast neoplastic growth with hyperplasia,
metaplasia, and dysplasia.
 Know the basic principles of the nomenclature of benign and malignant
processes.
 Define and use in the proper context:
 Adenoma.
 Papilloma.
 Polyp.
 Cystadenoma.
 Carcinoma.
 Adenocarcinoma.
 Sarcoma.
 Teratoma.
 Blastoma.
 Hamartoma.
Neoplasia
 Cancer is one of the leading causes of death
worldwide.
 Emotional and physical suffering by the
patient.
 Different mortality rate …..
 Some are curable
 Others are fatal
Neoplasia
 Neoplasia = new growth
 Neoplasm = tumor
 Tumor = swelling
 The study of tumors = Oncology
 Oncos = tumor + ology = study of
Neoplasia
 Definition:
 is an abnormal mass of tissue,
 the growth of which is uncoordinated with that of normal
tissues,
 and that persists in the same excessive manner after the
cessation of the stimulus which evoked the change“
 With the loss of responsiveness to normal growth controls
 Different from hyperplasia, metaplasia and dysplasia.
Neoplasia
 Classification
 Benign
 malignant
Neoplasia
 Benign tumors :
 Will remain localized
 Cannot spread to distant sites
 Generally can be locally excised
 Patient generally survives
Neoplasia
 Malignant neoplasms:
 Can invade and destroy adjacent structure
 Can spread to distant sites
 Cause death (if not treated )
Neoplasia
 All tumors have two basic components:
 Parechyma: made up of neoplastic cells
 Stroma: made up of non-neoplastic, host-
derived connective tissue and blood vessels
The parenchyma:
Determines the
biological behavior of
the tumor
From which the tumor
derives its name
The stroma:
Carries the blood supply
Provides support for the
growth of the
parenchyma
Neoplasia
 Nomenclature
 Benign tumors:
 prefix + suffix
 Type of cell + (-oma)
Neoplasia
 Examples:
 Benign tumor arising in fibrous tissue:
Fibro + oma = Fibroma
Benign tumor arising in fatty tissue:
Lipo + oma = lipoma
Neoplasia
 Benign tumor arising in cartilage
chondro + oma = chondroma
 Benign tumor arising in smooth muscle
Leiomyo + oma = leiomyoma
 Benign tumor arising in skeletal muscle
Rhabdomyo + oma = rhabdomyoma
Neoplasia
 epithelial benign tumors are classified on the
basis of :
 The cell of origin
 Microscopic pattern
 Macroscopic pattern
Neoplasia
 Adenoma : benign epithelial neoplasms producing
gland pattern….OR … derived from glands but not
necessarily exhibiting gland pattern
 Papilloma : benign epithelial neoplasms growing
on any surface that produce microscopic or
macroscopic finger-like pattern
Adenoma
Papilloma
Neoplasia
 Polyp : a mass that projects above a mucosal
surface to form a macroscopically visible
structure.
e.g. - colonic polyp
- nasal polyp
Polyp
Neoplasia
 Examples :
 Respiratory airways: Bronchial adenoma
 Renal epithelium: Renal tubular adenoma
 Liver cell : Liver cell adenoma
 Squamous epithelium: squamous papilloma
Neoplasia
 Malignant tumors:
 Malignant tumor arising in mesenchymal tissue :
SARCOMA
 From fibrous tissue: Fibrosarcoma
 From bone : Osteosarcoma
 From cartilage : chondrosarcoma
Osteosarcoma
Neoplasia
 Malignant tumors arising from epithelial origin
: CARCINOMA
 Squamous cell carcinoma
 Renal cell adenocarcinoma
 cholangiocarcinoma
Carcinomas arising from any epithelium of the body that exhibit
squamous differentiation are termed squamous cell carcinoma.
Nomenclature
other descriptive terms may be added such as:
Papillary Cystadenocarcinoma of the Ovary
Neoplasia
Exceptions
 Melanoma ( skin )
 Mesothelioma (mesothelium )
 Seminoma ( testis )
 Lymphoma ( lymphoid tissue )
Neoplasia
 Based on the biological behavior :
 Benign and malignant
 Based on the cell of origin :
 One neoplastic cell type : lipoma, adenocarcinoma
 More than one neoplastic cell type : fibroadenoma
 More than one neoplastic cell type derived from more
than one germ-cell layer: teratoma
 Derived from embryonic tissue: blastoma (could be
benign e.g. osteoblastoma, or malignant e.g. neuroblastoma)
Lipoma
Fibroadenoma
Teratoma
Neoplasia
 Teratoma:
 Teratoma contains recognizable mature or
immature cells or tissues representative of more
than one germ-cell layer and some times all
three.
 Teratomas originate from totipotential cells such
as those normally present in the ovary and testis.
Neoplasia
 Such cells have the capacity to differentiate into
any of the cell types found in the adult body. So
they may give rise to neoplasms that mimic bone,
epithelium, muscle, fat, nerve and other tissues.
 Most common sites are: ovary & testis
Neoplasia
 If all the components parts are well differentiated,
it is a benign (mature) teratoma.
 If less well differentiated, it is an immature
(malignant) teratoma.
Neoplasia nomenclature
- historic eponyms – “first described by…”
Malignant lymphoma (HL) of B Ly cell origin Hodgkin’s
disease
NHL – B Ly cell in children (jaw and GIT) Burkitt tumor
Bone tumor (PNET) Ewing tumor
Kidney tumor - clear cell adenocarcinoma Grawitz tumor
Malignant tumor derived from vascular epithelium
(AIDS)
Kaposi sarcoma
Ovarian tumor derived from Brenner cells Brenner tumor
Malignant chest wall tumor of PNET Askin tumor
Skin tumor derived from Merkel cell Merkel tumor
WHAT ARE HAMARTOMAS AND
CHORISTOMA?
Hamartoma: a mass composed of cells native
to the organ
e.g. pulmonary hamartoma.
Choristoma: a mass composed of normal
cells in a wrong location
e.g. pancreatic choristoma in liver or
stomach.
 Malformation and not neoplasm.
Pulmonary Hamartoma
Pancreatic choristoma in gall bladder
Neoplasia
Hamartoma and Choristoma
 They are distinguished from neoplasms by the fact
that they do not exhibit continued growth. they are
group of tumor-like tissue masses which may be
confused with neoplasms
Objectives
 Compare and contrast benign and malignant tumors with respect to:
 demarcation from surrounding tissue (capsule, local invasiveness.
 rate of growth
 degree of differentiation (Explain the meaning of differentiation).
 distant spread (metastases).
 Describe the morphologic changes associated with poorly differentiated tumors;
define and understand the usage of the terms anaplasia, pleomorphism, nuclear
atypia, abnormal mitoses and tumor giant cells.
 Understand the clinical significance of invasiveness and metastasis.
 Describe the anatomic pathways utilized by tumors in metastatic spread. Know
which pathways are commonly used by carcinomas versus sarcomas.
 List some common sites of distant metastases.
 Recognize the epidemiologic data of cancer distribution in regard to age, race,
geographic factors, and genetic backgrounds.
 List some inherited syndromes with a genetic predisposition to cancer.
Neoplasia
Characteristics of benign and malignant
neoplasms
 Differentiation and anaplasia
 Rate of growth
 Local invasion
 metastasis
Neoplasia
1. Differentiation and anaplasia:
. Differentiation means : the extent to which
the parenchymal cells of the tumor resemble
their normal counterparts morphologically
and functionally
Neoplasia
 well differentiated = closely resemble their
normal counterparts
 Moderately differentiated
 Poorly differentiated
 Undifferentiated ( Anaplasia )
Neoplasia
 Benign tumors = well differentiated
 Malignant tumors =
well differentiated -----> anaplastic
Neoplasia
 In the histological examination of a tumor you
should look for :
 Pleomorphism : variation in size
 High nuclear/ cytoplasm ratio ( N/C ratio)
 Hyperchrmasia ( dark cell )
 Mitosis ….?abnormal one
Neoplasia
Characteristics of benign and malignant
neoplasms
 Differentiation and anaplasia
 Rate of growth
 Local invasion
 metastasis
Neoplasia
 Rate of growth:
 Benign tumors:
 grows slowly
 are affected by blood supply, hormonal effects , location
 Malignant tumors :
 grows faster
 Correlate with the level of differentiation
Neoplasia
Characteristics of benign and malignant
neoplasms
 Differentiation and anaplasia
 Rate of growth
 Local invasion
 metastasis
Neoplasia
 Local invasion :
 Benign tumors :
 Remain localized
 Cannot invade
 Usually capsulated
 Malignant tumors :
 Progressive invasion
 Destruction
 Usually not capsulated
Neoplasia
Characteristics of benign and malignant
neoplasms
 Differentiation and anaplasia
 Rate of growth
 Local invasion
 Metastasis
Neoplasia
 Metastasis :
 Definition : the development of secondary
implants discontinuous with the primary tumor,
possibly in remote tissues
Neoplasia
 Metastasis :
 Cancers have different ability to metastasize
 Approximately 30% patients present with clinically
evident metastases.
 Generally, the more anaplastic and the larger the
primary tumor, the more likely is metastasis
Neoplasia
 Metastasis : three pathways
 Lymphatic spread :
 Hematogenous spread :
 Seeding of the body cavities: pleural, peritoneal
cavities and cerebral ventricles
Neoplasia
 Lymphatic spread :
 favored by carcinomas
 Breast carcinoma  axillary lymph nodes
 Lung carcinomas  bronchial lymph nodes
Neoplasia
 Hematogenous spread :
 favored by sarcomas
 Also used by carcinomas
 Veins are more commonly invaded
 The liver and lungs are the most frequently
involved secondary sites
Neoplasia
 In the histological examination of a tumor you
should look for :
 Pleomorphism : variation in size
 High nuclear/ cytoplasm ratio ( N/C ratio)
 Hyperchrmasia ( dark cell )
 Mitosis ….?abnormal one
Neoplasia
 Dysplasia :
 Definiton: a loss in the uniformity of the individual
cells and a loss in their architectural orientation.
 Non-neoplastic
 Occurs mainly in the epithelia
 Dysplastic cells shows a degree of : pleomorphism,
hyperchrmasia,increased mitosis and loss of
polarity.
Neoplasia
 Dysplasia does not mean cancer
 Dyplasia does not necessarily progress to
cancer
 Dysplasia may be reversible
 If dysplastic changes involve the entire
thickness of the epithelium it is called :
CARCINOMA IN-SITU
Neoplasia
 Carcinoma in-situ
 Definition: an intraepithelial malignancy in which
malignant cells involve the entire thickness of the
epithelium without penetration of the basement
membrane.
 Applicable only to epithelial neoplasms.
Dysplasia Features:
 Increased rate of
multiplication.
 Disordered
maturation.
• Nuclear abnormality
– Increased N/C ratio
– Irregular nuclear membrane
– Increased chromatin content
• Cytoplasmic abnormalities due
to failure of normal maturation
Dysplasia
Uterine cervix
Mild Dysplasia
Sever Dysplasia
Dysplasia (cervical pap smear)
Dysplasia
 Clinical significance:
 It is a premalignant condition.
 The risk of invasive cancer varies with:
 grade of dysplasia (mild, moderate, sever)
 duration of dysplasia
 site of dysplasia
Dysplasia
 Differences between dysplasia and cancer.
∗lack of invasiveness.
∗Reversibility
Carcinoma in situ
 A true neoplasm with all of the features of
malignant neoplasm except invasiveness
 Displays the cytological features of
malignancy without invasion of the basement
membrane.
Squamous cell Carcinoma
Uterine Cervix
Dysplasia
Neoplasia
 Epidemiology
 Will help to discover aetiology
 Planning of preventive measures
 To know what is common and what is rare.
 Development of screening methods for early
diagnosis
Neoplasia
 Factors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
Neoplasia
 Factors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
Neoplasia
 Geographic and Environmental factors:
 Rate of stomach carcinoma in Japan is seven times
the rate in North America and Europe.
 Breast carcinoma is five times higher in North
America comparing to Japan
 Liver cell carcinoma is more common in African
populations
Neoplasia
 Geographic and Environmental factors:
 Asbestos : mesothelioma
 Smoking : lung cancer
 Multiple sexual partners: cervical cancer
 Fatty diets : colonic cancer
Please see table 6-3 for occupational cancers
Neoplasia
 Factors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
Neoplasia
 Age:
 Generally, the frequency of cancer increases with
age.
 Most cancer mortality occurs between 55 and 75.
 Cancer mortality is also increased during
childhood
 Most common tumors of children: Leukemia,
tumors of CNS, Lymphomas, soft tissue and bone
sarcomas.
Neoplasia
 Factors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
Neoplasia
 Heredity
 Inherited Cancer Syndromes
 Familial Cancers
 Autosomal Recessive Syndromes of Defective DNA
repair
Heredity
 Inherited Cancer Syndromes:
 Inheritance of a single mutant gene greatly
increases the risk of developing neoplasm
 E.g. Retinoblastoma in children :
 40% of Retinoblastomas are familial
 carriers of the gene have 10000 fold increase in the risk of
developing Retinoblastoma
 E.g. multiple endocrine neoplasia
Heredity
 Familial Cancers:
 All common types of cancers occur in familial form
 E.g. breast, colon, ovary,brain
 Familial cancers usually have unique features:
 Start at early age
 Multiple or bilateral
 Two or more relatives
Heredity
 Autosomal Recessive Syndromes of Defective DNA
repair :
 Small group of autosomal recessive disorders
 Characterized by DNA instability
Please see table 6-4 for more examples
Neoplasia
 Factors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
Neoplasia
 Aquired preneoplastic disorders: Some
Clinical conditions that predispose to cancer
 Dysplastic bronchial mucosa in smokers lung
carcinoma
 Liver cirrhosis  liver cell carcinoma
 Margins of chronic skin fistula  squamous cell
carcinoma
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Necrosis
NecrosisNecrosis
Necrosis
 
Embolism
EmbolismEmbolism
Embolism
 
Embolism
EmbolismEmbolism
Embolism
 
Infarct
InfarctInfarct
Infarct
 
Pathologic Calcification
Pathologic CalcificationPathologic Calcification
Pathologic Calcification
 
Chronic granulomatous inflammation
Chronic granulomatous inflammationChronic granulomatous inflammation
Chronic granulomatous inflammation
 
Oedema new edited
Oedema new editedOedema new edited
Oedema new edited
 
Hyperplasia
HyperplasiaHyperplasia
Hyperplasia
 
Reversible cell injury I Pathology
Reversible cell injury I PathologyReversible cell injury I Pathology
Reversible cell injury I Pathology
 
Necrosis
NecrosisNecrosis
Necrosis
 
Granulomatous inflammation
Granulomatous inflammation Granulomatous inflammation
Granulomatous inflammation
 
Infarction
InfarctionInfarction
Infarction
 
Cellular adaptations
Cellular adaptationsCellular adaptations
Cellular adaptations
 
Pathology cell injury i
Pathology   cell injury iPathology   cell injury i
Pathology cell injury i
 
Mechanisms of cell injury
Mechanisms of cell injuryMechanisms of cell injury
Mechanisms of cell injury
 
Cell injury and Cellular Adaptation: Pathology
Cell injury and Cellular Adaptation: PathologyCell injury and Cellular Adaptation: Pathology
Cell injury and Cellular Adaptation: Pathology
 
Metaplasia
MetaplasiaMetaplasia
Metaplasia
 
Neoplasm
NeoplasmNeoplasm
Neoplasm
 
Pathophysiology of edema
Pathophysiology of edemaPathophysiology of edema
Pathophysiology of edema
 
Pathology of Acute Inflammation
Pathology of Acute InflammationPathology of Acute Inflammation
Pathology of Acute Inflammation
 

Ähnlich wie Neoplasia

2 pathological diagnosis of cancer
2 pathological diagnosis of cancer2 pathological diagnosis of cancer
2 pathological diagnosis of cancer
Sumit Prajapati
 
Neoplasia- and cancer related presentation
Neoplasia- and cancer related presentationNeoplasia- and cancer related presentation
Neoplasia- and cancer related presentation
MeMyself84
 
Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !
Ejaz Waris
 

Ähnlich wie Neoplasia (20)

Neoplasia,Growth,definition,Differentiation, .ppt
Neoplasia,Growth,definition,Differentiation, .pptNeoplasia,Growth,definition,Differentiation, .ppt
Neoplasia,Growth,definition,Differentiation, .ppt
 
Neoplasia 120107095645-phpapp01
Neoplasia 120107095645-phpapp01Neoplasia 120107095645-phpapp01
Neoplasia 120107095645-phpapp01
 
Neoplasia & carcinogenesis.pptx dr.jawahar singh.pptx 1
Neoplasia & carcinogenesis.pptx dr.jawahar singh.pptx 1Neoplasia & carcinogenesis.pptx dr.jawahar singh.pptx 1
Neoplasia & carcinogenesis.pptx dr.jawahar singh.pptx 1
 
neoplasia 1
 neoplasia  1 neoplasia  1
neoplasia 1
 
neoplasia.pptx
neoplasia.pptxneoplasia.pptx
neoplasia.pptx
 
2 pathological diagnosis of cancer
2 pathological diagnosis of cancer2 pathological diagnosis of cancer
2 pathological diagnosis of cancer
 
01 NEOPLASIA.pptx
01 NEOPLASIA.pptx01 NEOPLASIA.pptx
01 NEOPLASIA.pptx
 
Neoplasia- and cancer related presentation
Neoplasia- and cancer related presentationNeoplasia- and cancer related presentation
Neoplasia- and cancer related presentation
 
Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !
 
NEOPLASIA 2
NEOPLASIA 2NEOPLASIA 2
NEOPLASIA 2
 
Neoplasia.ppt
Neoplasia.pptNeoplasia.ppt
Neoplasia.ppt
 
-neoplsia-
-neoplsia--neoplsia-
-neoplsia-
 
neoplasia.pptx
neoplasia.pptxneoplasia.pptx
neoplasia.pptx
 
Neoplasia class 1.pptx
Neoplasia class 1.pptxNeoplasia class 1.pptx
Neoplasia class 1.pptx
 
NEOPLASIA: TUMOR NOMENCLATURE
NEOPLASIA: TUMOR NOMENCLATURE  NEOPLASIA: TUMOR NOMENCLATURE
NEOPLASIA: TUMOR NOMENCLATURE
 
Neoplasia: Nomenclature, Staging and Grading
Neoplasia: Nomenclature, Staging and GradingNeoplasia: Nomenclature, Staging and Grading
Neoplasia: Nomenclature, Staging and Grading
 
Neoplasia basics
Neoplasia basicsNeoplasia basics
Neoplasia basics
 
Neoplasia classification
Neoplasia   classificationNeoplasia   classification
Neoplasia classification
 
MECHANISM OF NEOPLASIA
MECHANISM OF NEOPLASIA MECHANISM OF NEOPLASIA
MECHANISM OF NEOPLASIA
 
Neoplasia - Patholgy
Neoplasia - Patholgy Neoplasia - Patholgy
Neoplasia - Patholgy
 

Mehr von Suraj Dhara

Mehr von Suraj Dhara (20)

SHOCK
SHOCKSHOCK
SHOCK
 
ACUTE INFLAMMATION
ACUTE INFLAMMATIONACUTE INFLAMMATION
ACUTE INFLAMMATION
 
EXAMINATION OF SWELLING
EXAMINATION OF SWELLING EXAMINATION OF SWELLING
EXAMINATION OF SWELLING
 
PAIN : HISTORY TAKING
PAIN : HISTORY TAKINGPAIN : HISTORY TAKING
PAIN : HISTORY TAKING
 
MANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMAMANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMA
 
DISEASE AND DENGUE
DISEASE AND DENGUEDISEASE AND DENGUE
DISEASE AND DENGUE
 
THE VESTIGIALS
THE VESTIGIALSTHE VESTIGIALS
THE VESTIGIALS
 
STAPHYLOCOCCUS
STAPHYLOCOCCUSSTAPHYLOCOCCUS
STAPHYLOCOCCUS
 
PNEUMOCOCCUS
PNEUMOCOCCUSPNEUMOCOCCUS
PNEUMOCOCCUS
 
SALMONELLA
SALMONELLASALMONELLA
SALMONELLA
 
PAIN : PATHOPHYSIOLOGY
PAIN : PATHOPHYSIOLOGYPAIN : PATHOPHYSIOLOGY
PAIN : PATHOPHYSIOLOGY
 
EPISTAXIS
EPISTAXISEPISTAXIS
EPISTAXIS
 
NASAL POLYP
NASAL POLYPNASAL POLYP
NASAL POLYP
 
FORENSIC MEDICINE MCQS
FORENSIC MEDICINE MCQSFORENSIC MEDICINE MCQS
FORENSIC MEDICINE MCQS
 
AMYLOIDOSIS
AMYLOIDOSISAMYLOIDOSIS
AMYLOIDOSIS
 
RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)
 
ANATOMY OF EXTERNAL EAR
ANATOMY OF EXTERNAL EARANATOMY OF EXTERNAL EAR
ANATOMY OF EXTERNAL EAR
 
ANATOMY OF LARYNX
ANATOMY OF LARYNXANATOMY OF LARYNX
ANATOMY OF LARYNX
 
CONCEPTS OF HEALTH AND DISEASE
CONCEPTS OF HEALTH AND DISEASECONCEPTS OF HEALTH AND DISEASE
CONCEPTS OF HEALTH AND DISEASE
 
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
 

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 

Neoplasia

  • 2. Neoplasia Upon completion of these lectures, the student should:  Define a neoplasm. Contrast neoplastic growth with hyperplasia, metaplasia, and dysplasia.  Know the basic principles of the nomenclature of benign and malignant processes.  Define and use in the proper context:  Adenoma.  Papilloma.  Polyp.  Cystadenoma.  Carcinoma.  Adenocarcinoma.  Sarcoma.  Teratoma.  Blastoma.  Hamartoma.
  • 3. Neoplasia  Cancer is one of the leading causes of death worldwide.  Emotional and physical suffering by the patient.  Different mortality rate …..  Some are curable  Others are fatal
  • 4. Neoplasia  Neoplasia = new growth  Neoplasm = tumor  Tumor = swelling  The study of tumors = Oncology  Oncos = tumor + ology = study of
  • 5. Neoplasia  Definition:  is an abnormal mass of tissue,  the growth of which is uncoordinated with that of normal tissues,  and that persists in the same excessive manner after the cessation of the stimulus which evoked the change“  With the loss of responsiveness to normal growth controls  Different from hyperplasia, metaplasia and dysplasia.
  • 7. Neoplasia  Benign tumors :  Will remain localized  Cannot spread to distant sites  Generally can be locally excised  Patient generally survives
  • 8. Neoplasia  Malignant neoplasms:  Can invade and destroy adjacent structure  Can spread to distant sites  Cause death (if not treated )
  • 9. Neoplasia  All tumors have two basic components:  Parechyma: made up of neoplastic cells  Stroma: made up of non-neoplastic, host- derived connective tissue and blood vessels The parenchyma: Determines the biological behavior of the tumor From which the tumor derives its name The stroma: Carries the blood supply Provides support for the growth of the parenchyma
  • 10.
  • 11.
  • 12. Neoplasia  Nomenclature  Benign tumors:  prefix + suffix  Type of cell + (-oma)
  • 13. Neoplasia  Examples:  Benign tumor arising in fibrous tissue: Fibro + oma = Fibroma Benign tumor arising in fatty tissue: Lipo + oma = lipoma
  • 14. Neoplasia  Benign tumor arising in cartilage chondro + oma = chondroma  Benign tumor arising in smooth muscle Leiomyo + oma = leiomyoma  Benign tumor arising in skeletal muscle Rhabdomyo + oma = rhabdomyoma
  • 15. Neoplasia  epithelial benign tumors are classified on the basis of :  The cell of origin  Microscopic pattern  Macroscopic pattern
  • 16. Neoplasia  Adenoma : benign epithelial neoplasms producing gland pattern….OR … derived from glands but not necessarily exhibiting gland pattern  Papilloma : benign epithelial neoplasms growing on any surface that produce microscopic or macroscopic finger-like pattern
  • 19. Neoplasia  Polyp : a mass that projects above a mucosal surface to form a macroscopically visible structure. e.g. - colonic polyp - nasal polyp
  • 20. Polyp
  • 21. Neoplasia  Examples :  Respiratory airways: Bronchial adenoma  Renal epithelium: Renal tubular adenoma  Liver cell : Liver cell adenoma  Squamous epithelium: squamous papilloma
  • 22. Neoplasia  Malignant tumors:  Malignant tumor arising in mesenchymal tissue : SARCOMA  From fibrous tissue: Fibrosarcoma  From bone : Osteosarcoma  From cartilage : chondrosarcoma
  • 24. Neoplasia  Malignant tumors arising from epithelial origin : CARCINOMA  Squamous cell carcinoma  Renal cell adenocarcinoma  cholangiocarcinoma
  • 25. Carcinomas arising from any epithelium of the body that exhibit squamous differentiation are termed squamous cell carcinoma.
  • 26. Nomenclature other descriptive terms may be added such as: Papillary Cystadenocarcinoma of the Ovary
  • 27. Neoplasia Exceptions  Melanoma ( skin )  Mesothelioma (mesothelium )  Seminoma ( testis )  Lymphoma ( lymphoid tissue )
  • 28. Neoplasia  Based on the biological behavior :  Benign and malignant  Based on the cell of origin :  One neoplastic cell type : lipoma, adenocarcinoma  More than one neoplastic cell type : fibroadenoma  More than one neoplastic cell type derived from more than one germ-cell layer: teratoma  Derived from embryonic tissue: blastoma (could be benign e.g. osteoblastoma, or malignant e.g. neuroblastoma)
  • 32. Neoplasia  Teratoma:  Teratoma contains recognizable mature or immature cells or tissues representative of more than one germ-cell layer and some times all three.  Teratomas originate from totipotential cells such as those normally present in the ovary and testis.
  • 33. Neoplasia  Such cells have the capacity to differentiate into any of the cell types found in the adult body. So they may give rise to neoplasms that mimic bone, epithelium, muscle, fat, nerve and other tissues.  Most common sites are: ovary & testis
  • 34. Neoplasia  If all the components parts are well differentiated, it is a benign (mature) teratoma.  If less well differentiated, it is an immature (malignant) teratoma.
  • 35. Neoplasia nomenclature - historic eponyms – “first described by…” Malignant lymphoma (HL) of B Ly cell origin Hodgkin’s disease NHL – B Ly cell in children (jaw and GIT) Burkitt tumor Bone tumor (PNET) Ewing tumor Kidney tumor - clear cell adenocarcinoma Grawitz tumor Malignant tumor derived from vascular epithelium (AIDS) Kaposi sarcoma Ovarian tumor derived from Brenner cells Brenner tumor Malignant chest wall tumor of PNET Askin tumor Skin tumor derived from Merkel cell Merkel tumor
  • 36. WHAT ARE HAMARTOMAS AND CHORISTOMA? Hamartoma: a mass composed of cells native to the organ e.g. pulmonary hamartoma. Choristoma: a mass composed of normal cells in a wrong location e.g. pancreatic choristoma in liver or stomach.  Malformation and not neoplasm.
  • 38. Pancreatic choristoma in gall bladder
  • 39. Neoplasia Hamartoma and Choristoma  They are distinguished from neoplasms by the fact that they do not exhibit continued growth. they are group of tumor-like tissue masses which may be confused with neoplasms
  • 40. Objectives  Compare and contrast benign and malignant tumors with respect to:  demarcation from surrounding tissue (capsule, local invasiveness.  rate of growth  degree of differentiation (Explain the meaning of differentiation).  distant spread (metastases).  Describe the morphologic changes associated with poorly differentiated tumors; define and understand the usage of the terms anaplasia, pleomorphism, nuclear atypia, abnormal mitoses and tumor giant cells.  Understand the clinical significance of invasiveness and metastasis.  Describe the anatomic pathways utilized by tumors in metastatic spread. Know which pathways are commonly used by carcinomas versus sarcomas.  List some common sites of distant metastases.  Recognize the epidemiologic data of cancer distribution in regard to age, race, geographic factors, and genetic backgrounds.  List some inherited syndromes with a genetic predisposition to cancer.
  • 41. Neoplasia Characteristics of benign and malignant neoplasms  Differentiation and anaplasia  Rate of growth  Local invasion  metastasis
  • 42. Neoplasia 1. Differentiation and anaplasia: . Differentiation means : the extent to which the parenchymal cells of the tumor resemble their normal counterparts morphologically and functionally
  • 43. Neoplasia  well differentiated = closely resemble their normal counterparts  Moderately differentiated  Poorly differentiated  Undifferentiated ( Anaplasia )
  • 44. Neoplasia  Benign tumors = well differentiated  Malignant tumors = well differentiated -----> anaplastic
  • 45.
  • 46.
  • 47.
  • 48. Neoplasia  In the histological examination of a tumor you should look for :  Pleomorphism : variation in size  High nuclear/ cytoplasm ratio ( N/C ratio)  Hyperchrmasia ( dark cell )  Mitosis ….?abnormal one
  • 49. Neoplasia Characteristics of benign and malignant neoplasms  Differentiation and anaplasia  Rate of growth  Local invasion  metastasis
  • 50. Neoplasia  Rate of growth:  Benign tumors:  grows slowly  are affected by blood supply, hormonal effects , location  Malignant tumors :  grows faster  Correlate with the level of differentiation
  • 51. Neoplasia Characteristics of benign and malignant neoplasms  Differentiation and anaplasia  Rate of growth  Local invasion  metastasis
  • 52. Neoplasia  Local invasion :  Benign tumors :  Remain localized  Cannot invade  Usually capsulated  Malignant tumors :  Progressive invasion  Destruction  Usually not capsulated
  • 53.
  • 54.
  • 55. Neoplasia Characteristics of benign and malignant neoplasms  Differentiation and anaplasia  Rate of growth  Local invasion  Metastasis
  • 56. Neoplasia  Metastasis :  Definition : the development of secondary implants discontinuous with the primary tumor, possibly in remote tissues
  • 57.
  • 58. Neoplasia  Metastasis :  Cancers have different ability to metastasize  Approximately 30% patients present with clinically evident metastases.  Generally, the more anaplastic and the larger the primary tumor, the more likely is metastasis
  • 59. Neoplasia  Metastasis : three pathways  Lymphatic spread :  Hematogenous spread :  Seeding of the body cavities: pleural, peritoneal cavities and cerebral ventricles
  • 60. Neoplasia  Lymphatic spread :  favored by carcinomas  Breast carcinoma  axillary lymph nodes  Lung carcinomas  bronchial lymph nodes
  • 61. Neoplasia  Hematogenous spread :  favored by sarcomas  Also used by carcinomas  Veins are more commonly invaded  The liver and lungs are the most frequently involved secondary sites
  • 62.
  • 63. Neoplasia  In the histological examination of a tumor you should look for :  Pleomorphism : variation in size  High nuclear/ cytoplasm ratio ( N/C ratio)  Hyperchrmasia ( dark cell )  Mitosis ….?abnormal one
  • 64. Neoplasia  Dysplasia :  Definiton: a loss in the uniformity of the individual cells and a loss in their architectural orientation.  Non-neoplastic  Occurs mainly in the epithelia  Dysplastic cells shows a degree of : pleomorphism, hyperchrmasia,increased mitosis and loss of polarity.
  • 65. Neoplasia  Dysplasia does not mean cancer  Dyplasia does not necessarily progress to cancer  Dysplasia may be reversible  If dysplastic changes involve the entire thickness of the epithelium it is called : CARCINOMA IN-SITU
  • 66.
  • 67. Neoplasia  Carcinoma in-situ  Definition: an intraepithelial malignancy in which malignant cells involve the entire thickness of the epithelium without penetration of the basement membrane.  Applicable only to epithelial neoplasms.
  • 68.
  • 69.
  • 70. Dysplasia Features:  Increased rate of multiplication.  Disordered maturation. • Nuclear abnormality – Increased N/C ratio – Irregular nuclear membrane – Increased chromatin content • Cytoplasmic abnormalities due to failure of normal maturation
  • 73. Dysplasia  Clinical significance:  It is a premalignant condition.  The risk of invasive cancer varies with:  grade of dysplasia (mild, moderate, sever)  duration of dysplasia  site of dysplasia
  • 74. Dysplasia  Differences between dysplasia and cancer. ∗lack of invasiveness. ∗Reversibility
  • 75. Carcinoma in situ  A true neoplasm with all of the features of malignant neoplasm except invasiveness  Displays the cytological features of malignancy without invasion of the basement membrane.
  • 77. Neoplasia  Epidemiology  Will help to discover aetiology  Planning of preventive measures  To know what is common and what is rare.  Development of screening methods for early diagnosis
  • 78.
  • 79.
  • 80.
  • 81. Neoplasia  Factors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 82. Neoplasia  Factors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 83. Neoplasia  Geographic and Environmental factors:  Rate of stomach carcinoma in Japan is seven times the rate in North America and Europe.  Breast carcinoma is five times higher in North America comparing to Japan  Liver cell carcinoma is more common in African populations
  • 84.
  • 85. Neoplasia  Geographic and Environmental factors:  Asbestos : mesothelioma  Smoking : lung cancer  Multiple sexual partners: cervical cancer  Fatty diets : colonic cancer Please see table 6-3 for occupational cancers
  • 86. Neoplasia  Factors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 87. Neoplasia  Age:  Generally, the frequency of cancer increases with age.  Most cancer mortality occurs between 55 and 75.  Cancer mortality is also increased during childhood  Most common tumors of children: Leukemia, tumors of CNS, Lymphomas, soft tissue and bone sarcomas.
  • 88. Neoplasia  Factors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 89. Neoplasia  Heredity  Inherited Cancer Syndromes  Familial Cancers  Autosomal Recessive Syndromes of Defective DNA repair
  • 90. Heredity  Inherited Cancer Syndromes:  Inheritance of a single mutant gene greatly increases the risk of developing neoplasm  E.g. Retinoblastoma in children :  40% of Retinoblastomas are familial  carriers of the gene have 10000 fold increase in the risk of developing Retinoblastoma  E.g. multiple endocrine neoplasia
  • 91. Heredity  Familial Cancers:  All common types of cancers occur in familial form  E.g. breast, colon, ovary,brain  Familial cancers usually have unique features:  Start at early age  Multiple or bilateral  Two or more relatives
  • 92. Heredity  Autosomal Recessive Syndromes of Defective DNA repair :  Small group of autosomal recessive disorders  Characterized by DNA instability Please see table 6-4 for more examples
  • 93. Neoplasia  Factors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 94. Neoplasia  Aquired preneoplastic disorders: Some Clinical conditions that predispose to cancer  Dysplastic bronchial mucosa in smokers lung carcinoma  Liver cirrhosis  liver cell carcinoma  Margins of chronic skin fistula  squamous cell carcinoma

Hinweis der Redaktion

  1. <number>
  2. <number>
  3. <number>
  4. <number>
  5. <number>
  6. <number>
  7. <number>
  8. <number>
  9. <number>
  10. <number>
  11. <number>
  12. <number>
  13. <number>
  14. <number>
  15. <number>
  16. Cervical SC carcinoma - infiltrating <number>